Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

Exclusion Criteria

• •Any major orthopedic or general surgery in the 3 months prior to study start;
• •Clinical signs or symptoms of DVT or PE within the last 12 months or known post phlebitic syndrome;
• •Any contra-indications to the performance of venography;
• •High risk of bleeding;
• •Known hypersensitivity to heparin or Enoxaparin sodium;
• •End stage renal disease or patient on dialysis.
• •The above information was not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.